Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹13,737 Cr
Revenue (TTM)
₹1,976 Cr
Net Profit (TTM)
₹126 Cr
ROE
6.9 %
ROCE
14.3 %
P/E Ratio
109
P/B Ratio
7
Industry P/E
44.47
EV/EBITDA
23.4
Div. Yield
0 %
Debt to Equity
0.1
Book Value
₹62.3
EPS
₹4
Face value
1
Shares outstanding
316,807,506
CFO
₹4,883.12 Cr
EBITDA
₹1,465.43 Cr
Net Profit
₹273.75 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Dr. Agarwal's Health Care
| -14.6 | -4.2 | -12.9 | 4.2 | -- | -- | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Dr. Agarwal's Health Care
|
434.0 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 |
| 230.4 | 3,655.3 | 1,041.9 | 96.4 | 12.0 | 11.5 | 37.8 | 3.1 | |
| 662.0 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 570.0 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 407.2 | 3,724.7 | 1,451.5 | 182.9 | 15.5 | 29.2 | 20.4 | 5.3 | |
| 1,282.0 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 5,299.2 | 5,798.5 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.6 | 4.6 | |
| 201.1 | 8,679.7 | 1,393.6 | 213.2 | -- | 22.1 | 42.3 | 4.6 | |
| 1,123.9 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 673.3 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and... refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India. Read more
Incorporated
2010
Chairman
--
Managing Director
--
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about Dr. Agarwal's Health Care Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Dr Agarwal's Health Care Ltd is ₹433.95 (NSE) and ₹433.60 (BSE) as of 18-Mar-2026 IST. Dr Agarwal's Health Care Ltd has given a return of 4.21% in the last 1 years.
The P/E ratio of Dr Agarwal's Health Care Ltd is 108.98 times as on 18-Mar-2026, a 145 premium to its peers’ median range of 44.47 times.
The P/B ratio of Dr Agarwal's Health Care Ltd is 6.96 times as on 18-Mar-2026, a 8 premium to its peers’ median range of 6.43 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
169.15
|
7.60
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Dr Agarwal's Health Care Ltd are Rs 568.00 and Rs 327.00 as of 19-Mar-2026.
Dr Agarwal's Health Care Ltd has a market capitalisation of ₹ 13,737 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Dr Agarwal's Health Care Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹7.70
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.